{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:52:25Z","timestamp":1790632345533,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To examine user uptake and experience with a clinical chatbot that automates hereditary cancer risk triage by collecting personal and family cancer history in routine women's health care settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a multicenter, retrospective observational study of patients who used a web-based chatbot before routine care appointments to assess their risk for hereditary breast and ovarian cancer, Lynch syndrome, and adenomatous polyposis syndromes. Outcome measures included uptake and completion of the risk-assessment and educational section of the chatbot interaction and identification of hereditary cancer risk as evaluated against National Comprehensive Cancer Network criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of the 95,166 patients invited, 61,070 (64.2%) engaged with the clinical chatbot. The vast majority completed the cancer risk assessment (89.4%), and most completed the genetic testing education section (71.4%), indicating high acceptability among those who opted to engage. The mean duration of use was 15.4 minutes (SD 2 hours, 56.2 minutes) when gaps of inactivity longer than 5 minutes were excluded. A personal history of cancer was reported by 19.1% (10,849\/56,656) and a family history of cancer was reported by 66.7% (36,469\/54,652) of patients who provided the relevant information. One in four patients (14,850\/54,547) screened with the chatbot before routine care appointments met National Comprehensive Cancer Network criteria for genetic testing. Among those who were tested, 5.6% (73\/1,313) had a disease-causing pathogenic variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>A chatbot digital health tool can help identify patients at high risk for hereditary cancer syndromes before routine care appointments. This scalable intervention can effectively provide cancer risk assessment, engage patients with educational information, and facilitate a path toward preventive genetic testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING SOURCE:<\/jats:title>\n                    <jats:p>Implementation of the chatbot in clinics was funded by industry support from commercial genetic testing laboratories Ambry, Invitae, and Progenity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004596","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T17:02:14Z","timestamp":1636045334000},"page":"860-870","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":85,"title":["Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits"],"prefix":"10.1097","volume":"138","author":[{"given":"Shivani","family":"Nazareth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Snir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Hatchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rojahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Nathan","family":"Slotnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"kab044","DOI":"10.1093\/jncics\/pkab044","article-title":"Penetrance of breast cancer susceptibility genes from the eMERGE III network","volume":"5","author":"Fan","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/gim.2017.145","article-title":"Early cancer diagnoses through BRCA1\/2 screening of unselected adult biobank participants","volume":"20","author":"Buchanan","year":"2018","journal-title":"Genet Med"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41436-020-0876-4","article-title":"Clinical outcomes of a genomic screening program for actionable genetic conditions","volume":"22","author":"Buchanan","year":"2020","journal-title":"Genet Med"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amepre.2017.10.015","article-title":"Provider discussions of genetic tests with U.S. women at risk for a BRCA mutation","volume":"54","author":"Hull","year":"2018","journal-title":"Am J Prev Med"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gim.2014.68","article-title":"Characteristics associated with genetic counseling referral and BRCA1\/2 testing among women in a large integrated health system","volume":"17","author":"Bellcross","year":"2015","journal-title":"Genet Med"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","article-title":"National estimates of genetic testing in women with a history of breast or ovarian cancer","volume":"35","author":"Childers","year":"2017","journal-title":"J Clin Oncol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.30621","article-title":"Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors","volume":"123","author":"Cragun","year":"2017","journal-title":"Cancer"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/AOG.0000000000002296","article-title":"Hereditary breast and ovarian cancer syndrome. Practice Bulletin No. 182. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","article-title":"American Society of Clinical Oncology expert statement: collection and use of a cancer family history for oncology providers","volume":"32","author":"Lu","year":"2014","journal-title":"J Clin Oncol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/gtmb.2009.0037","article-title":"Cancer genetic risk assessment and referral patterns in primary care","volume":"13","author":"Vig","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10897-014-9813-5","article-title":"All in the family: barriers and motivators to the use of cancer family history questionnaires and the impact on attendance rates","volume":"24","author":"Armel","year":"2015","journal-title":"J Genet Couns"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s13187-017-1240-5","article-title":"Identifying primary care physicians continuing education needs by examining clinical practices, attitudes, and barriers to screening across multiple cancers","volume":"33","author":"Lynn","year":"2018","journal-title":"J Cancer Educ"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1090198119853002","article-title":"Patterns of communicating about family health history: exploring differences in family types, age, and sex","volume":"46","author":"Campbell-Salome","year":"2019","journal-title":"Health Educ Behav"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jgc4.1359","article-title":"Chatbots & artificial intelligence to scale genetic information delivery","volume":"30","author":"Nazareth","year":"2021","journal-title":"J Genet Couns"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"e15787","DOI":"10.2196\/15787","article-title":"A chatbot versus physicians to provide information for patients with breast cancer: blind, randomized controlled noninferiority trial","volume":"21","author":"Bibault","year":"2019","journal-title":"J Med Internet Res"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/AOG.0000000000001405","article-title":"Prenatal diagnostic testing for genetic disorders. Practice Bulletin No. 162. American College of Obstetricians and Gynecologists","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/jgc4.1169","article-title":"Patient assessment of chatbots for the scalable delivery of genetic counseling","volume":"28","author":"Schmidlen","year":"2019","journal-title":"J Genet Couns"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10689-015-9852-6","article-title":"Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer","volume":"15","author":"Douma","year":"2016","journal-title":"Fam Cancer"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10897-016-0040-0","article-title":"Why is cancer genetic counseling underutilized by women identified as at risk for hereditary breast cancer? Patient perceptions of barriers following a referral letter","volume":"26","author":"Kne","year":"2017","journal-title":"J Genet Couns"},{"key":"R23-20260916","first-page":"340","article-title":"Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancers","volume":"32","author":"Swink","year":"2019","journal-title":"Proc"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jgc4.1319","article-title":"Genetic counseling service delivery models: a study of genetic counselors' interests, needs, and barriers to implementation","volume":"30","author":"Boothe","year":"2021","journal-title":"J Genet Couns"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jgc4.1041","article-title":"Genetic counselor workflow study: the times are they a-changin\u2019?","volume":"28","author":"Attard","year":"2019","journal-title":"J Genet Couns"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.5888\/pcd17.200257","article-title":"Prevalence and correlates of family cancer history knowledge and communication among US adults","volume":"17","author":"Krakow","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ypmed.2015.04.007","article-title":"Impact of family history assessment on communication with family members and health care providers: a report from the Family HealthwareTM Impact Trial (FHITr)","volume":"77","author":"Wang","year":"2015","journal-title":"Prev Med"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000003562","article-title":"Hereditary cancer syndromes and risk assessment. ACOG Committee Opinion No. 793. American College of Obstetricians and Gynecologists","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1245\/s10434-020-09123-z","article-title":"Adherence to NCCN guidelines for genetic testing in breast cancer patients: who are we missing?","volume":"28","author":"Alberty-Oller","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000294415","article-title":"Health Heritage\u00a9 a web-based tool for the collection and assessment of family health history: initial user experience and analytic validity","volume":"13","author":"Cohn","year":"2010","journal-title":"Public Health Genomics"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10689-015-9863-3","article-title":"Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment","volume":"15","author":"Baumgart","year":"2016","journal-title":"Fam Cancer"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13053-018-0099-8","article-title":"Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes","volume":"17","author":"Bucheit","year":"2019","journal-title":"Hered Cancer Clin Pract"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1002\/cphg.72","article-title":"Obtaining a genetic family history using computer-based tools","volume":"100","author":"Li","year":"2019","journal-title":"Curr Protoc Hum Genet"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"e16222","DOI":"10.2196\/16222","article-title":"Trust Me, I'm a chatbot: how artificial intelligence in health care fails the Turing test","volume":"21","author":"Powell","year":"2019","journal-title":"J Med Internet Res"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.c.31602","article-title":"The past, present and future of service delivery in genetic counseling: keeping up in the era of precision medicine","volume":"178","author":"Stoll","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:29Z","timestamp":1789556489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004596","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"assertion":[{"value":"2021-06-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}